financetom
Business
financetom
/
Business
/
Copart Names Jeff Liaw as CEO, Jay Adair as Executive Chairman
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Copart Names Jeff Liaw as CEO, Jay Adair as Executive Chairman
Mar 11, 2024 2:02 PM

04:37 PM EDT, 03/11/2024 (MT Newswires) -- Copart ( CPRT ) said its board appointed Jeff Liaw, its co-chief executive officer since March 2022, as its sole CEO.

Jay Adair, who has been the company's CEO for ten years to February 2022 and as co-CEO along with Liaw since March 2022, will step down, the company said late Monday. The board appointed Adair as executive chairman.

The company said the changes will come into effect from April 1.

Liaw joined Copart ( CPRT ) in 2016 as the chief financial officer before being promoted to president in 2019.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Alphabet Q1 Cloud Revenue at $9.57 Billion vs Visible Alpha Analyst Consensus of $9.38 Billion
--Alphabet Q1 Cloud Revenue at $9.57 Billion vs Visible Alpha Analyst Consensus of $9.38 Billion
Apr 25, 2024
04:04 PM EDT, 04/25/2024 (MT Newswires) -- Price: 172.16, Change: +14.21, Percent Change: +9.00 ...
Google parent Alphabet announces first-ever dividend of 20 cents per share
Google parent Alphabet announces first-ever dividend of 20 cents per share
Apr 25, 2024
(Reuters) - Alphabet announced its first-ever dividend of 20 cents per share on Thursday, returning capital when the Google parent is spending billions of dollars on data centers to catch up with rivals on generative artificial intelligence. Shares of the rose nearly 13% in trading after the bell. Alphabet also said it had authorized the repurchase of up to an...
Gilead posts quarterly loss, revenue rises 5%
Gilead posts quarterly loss, revenue rises 5%
Apr 25, 2024
April 25 (Reuters) - Gilead Sciences ( GILD ) reported a first-quarter loss on Thursday after taking a $3.9 billion charge for its recent acquisition of liver drug developer CymaBay Therapeutics, while revenue rose 5% on higher HIV, oncology and liver disease treatment sales. For full-year 2024, Gilead said it still expects product sales of $27.1 billion to $27.5 billion,...
Kraken Robotics Raising C$17.5 Million in a Bought Deal Public Share Offering
Kraken Robotics Raising C$17.5 Million in a Bought Deal Public Share Offering
Apr 25, 2024
04:01 PM EDT, 04/25/2024 (MT Newswires) -- Kraken Robotics ( KRKNF ) on Thursday said it is raising C$17.5 million in a bought deal public share offering. The company is selling and underwriting syndicate 18.4-million priced at C$0.95 each, while also granting a 15% over-allotment option. Kraken expects to use the net proceeds to facilitate its long term strategy, including...
Copyright 2023-2026 - www.financetom.com All Rights Reserved